Teladoc Health (NYSE:TDOC) Price Target Raised to $11.00

Teladoc Health (NYSE:TDOC) had its target price hoisted by Canaccord Genuity Group from $10.00 to $11.00 in a research report sent to investors on Tuesday morning,Benzinga reports. The firm currently has a buy rating on the health services provider’s stock.

A number of other equities analysts also recently weighed in on TDOC. Citigroup upped their price target on Teladoc Health from $6.00 to $7.00 and gave the stock a “neutral” rating in a research report on Tuesday, May 5th. Bank of America lifted their price objective on shares of Teladoc Health from $9.00 to $10.50 and gave the company a “buy” rating in a report on Tuesday, July 7th. Weiss Ratings raised shares of Teladoc Health from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Friday, May 22nd. Finally, Barclays reduced their target price on shares of Teladoc Health from $8.50 to $7.00 and set an “equal weight” rating for the company in a report on Thursday, March 26th. Five investment analysts have rated the stock with a Buy rating, eleven have issued a Hold rating and one has given a Sell rating to the company. According to MarketBeat, the company has an average rating of “Hold” and an average price target of $7.73.

Teladoc Health Stock Performance

TDOC opened at $8.68 on Tuesday. The company has a market capitalization of $1.57 billion, a price-to-earnings ratio of -8.95 and a beta of 2.10. The business’s 50-day moving average price is $8.00 and its two-hundred day moving average price is $6.51. Teladoc Health has a 1 year low of $4.40 and a 1 year high of $9.89. The company has a debt-to-equity ratio of 0.75, a current ratio of 2.80 and a quick ratio of 2.72.

Teladoc Health (NYSE:TDOC) last posted its quarterly earnings data on Wednesday, April 29th. The health services provider reported ($0.36) earnings per share for the quarter, missing the consensus estimate of ($0.35) by ($0.01). Teladoc Health had a negative return on equity of 11.45% and a negative net margin of 6.81%.The firm had revenue of $613.85 million for the quarter, compared to analyst estimates of $611.04 million. During the same period in the prior year, the company earned ($0.53) earnings per share. The firm’s quarterly revenue was down 2.5% on a year-over-year basis. Teladoc Health has set its FY 2026 guidance at -1.050–0.750 EPS and its Q2 2026 guidance at -0.300–0.200 EPS. Equities analysts expect that Teladoc Health will post -0.92 EPS for the current fiscal year.

Insider Buying and Selling

In other Teladoc Health news, insider Carlos Nueno sold 6,196 shares of the company’s stock in a transaction on Tuesday, June 2nd. The shares were sold at an average price of $7.63, for a total transaction of $47,275.48. Following the sale, the insider directly owned 57,671 shares of the company’s stock, valued at approximately $440,029.73. This represents a 9.70% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CEO Charles Divita III sold 19,132 shares of the stock in a transaction on Tuesday, June 2nd. The shares were sold at an average price of $7.63, for a total transaction of $145,977.16. Following the completion of the sale, the chief executive officer owned 389,894 shares of the company’s stock, valued at approximately $2,974,891.22. This represents a 4.68% decrease in their position. The SEC filing for this sale provides additional information. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders sold 39,195 shares of company stock worth $299,058 over the last 90 days. Company insiders own 0.70% of the company’s stock.

Institutional Inflows and Outflows

Several institutional investors have recently modified their holdings of TDOC. EverSource Wealth Advisors LLC lifted its stake in Teladoc Health by 694.5% in the 1st quarter. EverSource Wealth Advisors LLC now owns 5,657 shares of the health services provider’s stock valued at $31,000 after purchasing an additional 4,945 shares during the last quarter. PNC Financial Services Group Inc. increased its position in Teladoc Health by 177.7% during the fourth quarter. PNC Financial Services Group Inc. now owns 4,391 shares of the health services provider’s stock worth $31,000 after buying an additional 2,810 shares during the last quarter. IFP Advisors Inc raised its stake in Teladoc Health by 412.1% in the third quarter. IFP Advisors Inc now owns 3,989 shares of the health services provider’s stock valued at $31,000 after buying an additional 3,210 shares during the period. International Assets Investment Management LLC bought a new stake in Teladoc Health in the fourth quarter valued at approximately $45,000. Finally, Van ECK Associates Corp lifted its position in shares of Teladoc Health by 101.4% in the fourth quarter. Van ECK Associates Corp now owns 9,150 shares of the health services provider’s stock valued at $64,000 after buying an additional 4,607 shares during the last quarter. 76.82% of the stock is currently owned by institutional investors and hedge funds.

About Teladoc Health

Teladoc Health, Inc is a leading global provider of virtual healthcare services, offering on-demand medical consultations via phone, video, and mobile app platforms. The company connects patients with licensed physicians and specialists for non-emergency medical issues, mental health support, dermatology, and chronic condition management. By leveraging digital technologies and data analytics, Teladoc aims to enhance accessibility, reduce healthcare costs, and improve patient outcomes through personalized care plans and remote monitoring.

Teladoc’s service portfolio includes general medical visits, behavioral health sessions, expert medical services for complex cases, and wellness programs designed to support chronic disease management such as diabetes, hypertension, and heart disease.